Windlas Biotech board to meet for Q2 and H1 financials

Windlas Biotech Limited announced a Board of Directors meeting scheduled for Thursday, November 6, 2025. The primary agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. This notice was issued on October 29, 2025, to both the BSE Limited and the National Stock Exchange of India Limited.

In accordance with SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window for designated persons of the company closed on October 1, 2025. This closure was communicated via a letter dated September 29, 2025, and will reopen 48 hours after the declaration of the financial results.

The announcement was made by Ananta Narayan Panda, company secretary & compliance officer of Windlas Biotech Limited.